NA
KRMD icon

Navellier & Associates’s KORU Medical Systems KRMD Stock Holding History

Navellier & Associates’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,853
Closed -$77K – 304
2020
Q4 		$77K Buy
12,853
+30
+0.2% +$168 0.01% 273
2020
Q3 		$93K Sell
12,823
-2,544
-17% -$22.6K 0.02% 223
2020
Q2 		$138K Sell
15,367
-33,818
-69% -$342K 0.03% 225
2020
Q1 		$369K Buy
49,185
+13,185
+37% +$88.7K 0.09% 159
2019
Q4 		$235K Buy
+36,000
New +$176K 0.04% 261

Other funds holding KRMD

HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Navellier & Associates's KRMD Position: Q1 2021 in Review

Navellier & Associates sold out of KORU Medical Systems (KRMD) in Q1 2021, closing a stake of 12,853 shares — an estimated $77K sold.

Navellier & Associates first reported a position in KRMD in Q4 2019 and held it in 5 quarters. The position peaked at $369K in Q1 2020. 72 funds tracked by Wall St. Rank hold KRMD as of Q1 2021.

  • Navellier & Associates reported no remaining KORU Medical Systems position as of Q1 2021 after selling out during the quarter.
  • Navellier & Associates sold 12,853 KORU Medical Systems shares in Q1 2021, an estimated $77K.
  • Navellier & Associates first reported a position in KORU Medical Systems in Q4 2019 and held it in 5 quarters.
  • Navellier & Associates's KORU Medical Systems position peaked at $369K in Q1 2020.
  • 72 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2021.

Based on Navellier & Associates's 13F filing for Q1 2021, filed 12 May 2021.